Susan A. Knudson - 10 Mar 2023 Form 4 Insider Report for Histogen Inc.

Reporting relationship: COO and CFO
Issuer ticker: N/A
Reported as of: 10 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Mar 2023, 16:33:04 UTC
Prior SEC filing: 09 Nov 2022
Source filing: View source filing
Reporting owner signature: /s/ Susan A. Knudson

Key filing fact

Susan A. Knudson filed Form 4 for Histogen Inc. on 14 Mar 2023.

Key facts

This page summarizes Susan A. Knudson's Form 4 filing for Histogen Inc..
5 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 14 Mar 2023, 16:33.

Change

Previous filing in this sequence was filed on 09 Nov 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HSTO transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +79,027
Change %
Price: $0.000000
Shares after: 79,027
Date: 10 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 79,027
Exercise price: $0.9500
Footnotes: F1

HSTO transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +27,766
Change %
Price: $0.000000
Shares after: 27,766
Date: 10 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 27,766
Exercise price: $0.9500
Footnotes: F1, F2

HSTO transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -6,206
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 10 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,206
Exercise price: $92.20
Footnotes: F3, F4, F5

HSTO transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -5,600
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 10 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,600
Exercise price: $19.40
Footnotes: F3, F4, F6

HSTO transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value: $0
Shares: -8,490
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 10 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,490
Exercise price: $4.80
Footnotes: F3, F4, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

1/4 of the shares subject to the option vest one year after the date of grant, on 3/10/2024, and the remaining 1/36 of the shares vest on a monthly basis thereafter.

Footnote F2

The shares subject to this option are subject to forfeiture in the event that the shares available pursuant to the Issuer's 2020 Incentive Award Plan are not increased prior to the one-year anniversary and vesting of the award by an amount required to be available for issuance for all outstanding stock awards containing this forfeiture condition.

Footnote F3

Effective June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of the Company's issued and outstanding common stock, par value $0.0001 per share.

Footnote F4

On March 10, 2023, the Issuer and the Reporting Person agreed to cancel the stock option award.

Footnote F5

1/4 of the shares subject to the option vested one year after the date of grant, on 5/27/2021, and the remaining 1/36 of the shares vest on a monthly basis thereafter.

Footnote F6

1/4 of the shares subject to the option vested one year after the date of grant, on 1/13/2022, and the remaining 1/36 of the shares vest on a monthly basis thereafter.

Footnote F7

1/4 of the shares subject to the option vested one year after the date of grant, on 2/17/2023, and the remaining 1/36 of the shares vest on a monthly basis thereafter.